Company Close Updates

TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors

Company Logo

Terrence Horan

Referenced Symbols

Shares of TherapeuticsMD Inc. TXMD, +1.29% sank 0.44% to $0.74 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP, -0.05% rising 1.73% to 14,823.43 and the Dow Jones Industrial Average DJIA, +0.43% rising 1.56% to 34,912.56. The stock's fall snapped a three-day winning streak. TherapeuticsMD Inc. closed $2.01 short of its 52-week high ($2.75), which the company achieved on February 9th.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson JNJ, -0.05% rose 0.57% to $160.11, Merck & Co. Inc. MRK, +1.99% fell 0.79% to $78.33, and Novartis AG ADR NVS, +1.59% rose 0.21% to $82.60. Trading volume (2.7 M) remained 2.6 million below its 50-day average volume of 5.3 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.